EYENOVATE Agenda
EYENOVATE & Retina Futura Clinical Trials | PRELIMINARY TOPICS
PRELIMINARY TOPICS
- Translating science into medicine
- Capital Market Outlook
- Assessing investment risk
- Redefining care of chronic prevalent retinal diseases: new therapeutic advances
- New therapeutic advances in Inherited Retinal diseases
- Emerging treatments for dry AMD: what to expect in the near future?
- Next generation revolution: spotlight on latest innovation in retinal diseases
- Accelerating drug development: the future of clinical trial development and study design for retina clinical programs
- Supporting research at the intersection of regulatory policy & science: on what truisms can we rely?
- Ophthalmology investment outlook
- EYENOVATE DOLPHIN TANK
